Heard, J., & Kölker, S. (2020). Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network. Orphanet journal of rare diseases, 15, . https://doi.org/10.1186/s13023-019-1280-5
Chicago-Zitierstil (17. Ausg.)Heard, Jean-Michel, und Stefan Kölker. "Availability, Accessibility and Delivery to Patients of the 28 Orphan Medicines Approved by the European Medicine Agency for Hereditary Metabolic Diseases in the MetabERN Network." Orphanet Journal of Rare Diseases 15 (2020). https://doi.org/10.1186/s13023-019-1280-5.
MLA-Zitierstil (9. Ausg.)Heard, Jean-Michel, und Stefan Kölker. "Availability, Accessibility and Delivery to Patients of the 28 Orphan Medicines Approved by the European Medicine Agency for Hereditary Metabolic Diseases in the MetabERN Network." Orphanet Journal of Rare Diseases, vol. 15, 2020, https://doi.org/10.1186/s13023-019-1280-5.